Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PPM1G mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PPM1G mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of PPM1G mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PPM1G mRNA | affects expression | 17562736
|
D002330 |
Carmustine |
Carmustine results in decreased expression of PPM1G mRNA | decreases expression | 15980968
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PPM1G mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PPM1G mRNA | increases expression | 17942748 16174780
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPM1G mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of PPM1G mRNA | increases expression | 16174780
|
C030110 |
oxaliplatin |
oxaliplatin results in increased expression of PPM1G mRNA | increases expression | 17762391
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PPM1G mRNA | decreases expression | 16014739
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of PPM1G mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PPM1G mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PPM1G mRNA | increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PPM1G protein | decreases expression | 16548065
|
D013876 |
Thiophenes |
Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of PPM1G mRNA] | decreases expression|increases reaction | 16140955
|
D014212 |
Tretinoin |
Thiophenes analog promotes the reaction [Tretinoin results in decreased expression of PPM1G mRNA] | decreases expression|increases reaction | 16140955
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of PPM1G mRNA | decreases expression | 16140955
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.72 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
9.00 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.00 | 14514962 11752688 15322242 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.87 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.08 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.70 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.02 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.42 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.42 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.29 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.37 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.53 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.31 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.31 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001932 |
Brain Neoplasms |
|
Carmustine |
4.49 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.83 | 21138602 15565566 19244106 19115204 19288272 19011961 17242785 17049068 20005174 19221464 19103187 18855134 18425577 20544844 17261762 16873071 18984771 19487384 18997820 17893378 19200415 19155303 16202921 18815881 20859285 18351453 18821012 15668708 19289846 17440819 19142967 19189210 16273361 20135344 19059307 19410462 19066611 11161223 20065188 19189212 18629630 19084267 20390343 16818667 21152245 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.83 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.83 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.74 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.64 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.33 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
11.61 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.61 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.61 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.61 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
11.61 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.61 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.78 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.78 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.72 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
12.73 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
12.73 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
12.73 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
6.99 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.99 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.74 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.95 | 11677210 16919318 17110522 17681005 15861022 16105132 17333356 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.33 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.90 | 15668235 8697196 15340226 16354765 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.90 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.84 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
3.19 | 16004971 16510598 16024531 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
2.94 | 18509181 18448328 17695437 17255274 17594712 17401013 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.52 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.52 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.48 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.48 | 9142499 10589399 9211117 17551590 14991402 16925845 9664655 8800419 9224671 9125849 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.36 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.36 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.50 | 19031437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.57 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
12.34 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.34 | 17562736 16177239 19164858 18713872 19420014 15968718 16393943 19085960 12594235 14986274 15619225 17906064 12153990 12705907 12392966 11739529 19923254 18071297 17522070 16109766 2444490 19416960 12540782 16081117 19370779 11743745 16485898 11461765 10663392 11834606 11421492 11287661 14550746 19739265 10774834 16781746 11529661 16227642 14725611 12958197 10915739 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.34 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.27 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.53 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.53 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.37 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.37 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.67 | 16202921 19155303 20544844 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.67 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.11 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.11 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
8.06 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
8.06 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.30 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.68 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.34 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.09 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.09 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.85 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.83 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Carmustine |
7.69 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.69 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.26 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.33 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.72 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.72 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.25 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 18606429 8697196 16959395 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
13.68 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
13.68 | 17418472 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
13.68 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.71 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.88 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.88 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.07 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.07 | 12878042 12200463 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.90 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.30 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.30 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.16 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.16 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.95 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.95 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.95 | 18625569 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.82 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.81 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.09 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Thiophenes |
8.46 | 16140955 16140954 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
8.46 | 19075265 15748426 17301526 17217047 19225113 16140955 16891316 17339181 17294898 16331271 16935935 16766008 17361223 17107899 16823087 17712046 9834237 17368321 19029980 17506722 16788101 12679006 19035177 17649720 19642359 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.38 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.23 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.51 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.51 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.51 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.65 | 19460945 16611625 19014921 19784758 12587719 11587558 16610002 12969438 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.34 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.01 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
11.01 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
11.01 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.01 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
5.95 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.95 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.24 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.45 | 17077188 19931552 17306315 15276417 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.45 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.45 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.91 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.69 | 11731420 19196722 14580682 19196723 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.72 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.82 | 17453147 |
MESH:D008545 |
Melanoma |
|
Carmustine |
7.49 | 12393984 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.49 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
7.49 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.49 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.34 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.71 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.56 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.14 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.87 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.87 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.58 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.55 | 19410462 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.28 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.28 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.80 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.17 | 19189210 19200415 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.94 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.94 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.54 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.54 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.96 | 18514411 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.77 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.77 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
15.77 | 14694615 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.99 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.99 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
6.89 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.89 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.50 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11896295 11399792 11222880 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.23 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.23 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.72 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.95 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.22 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.11 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.11 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.71 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.71 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.71 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
12.15 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
12.15 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.19 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.88 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.11 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.89 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.29 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.25 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
12.25 | 16452187 16712894 11723127 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.25 | 17572228 16712894 8653321 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.51 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.51 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.09 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.76 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.76 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.78 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.18 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.07 | 16287080 |